Τόμος 18 (2004) – Τεύχος 1 – Άρθρο 47 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 18 (2004) – Issue 1 – Article 47 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Alterations in brain neurotransmitters in B(a)P exposed rats: role of D2 receptors
Author Panagiotis Harkitis1, Panagiotis Tzimas1, Marios Marselos1, Elizabeth O. Johnson2 and Maria Konstandi1

1Dept of Pharmacology, Medical School, University of loannina, loannina GR-451 10, Greece;

2Dept of Anatomy, Medical School, University of loannina, loannina GR-451 10, Greece

Citation Harkitis, P., Tzimas, P., Marselos, M., Johnson, E.O. and Konstandi, M.: Alterations in brain neurotransmitters in B(a)P exposed rats: role of D2 receptors, Epitheorese Klin. Farmakol. Farmakokinet. 18(1): 117-120 (2004)
Publication Date Accepted for publication: 2004
Full Text Language English
Order – Buy Ηλεκτρονική Μορφή: pdf (10 €)Digital Type: pdf (10 €) pharmakonpress[at]pharmakonpress[.]gr
Keywords B(α)P, Brain Neurotransmitters, Alterations, D2 Receptors, L-DOPA, Polycyclic Aromatic Hydrocarbon, PAH
Other Terms review article
Summary Benzo(a)pyrene (B(a)P) (10mg/kg bwx3, ip), a representative polycyclic aromatic hydrocarbon (PAH), changed dopaminergic activity in hippocampus as assessed by dopamine (DA) ieveis and turnover. This effect is likely mediated via D2 receptors, as sulpiride eliminated the stimulating effect of B(a)P. Similarly, B(a)P increased noradrenaline (NA) levels in both hypothalamus and hippocampus and sulpiride blocked this effect. L-DOPA increased DA levels and turnover in both brain sites tested, a fact that was suppressed at some extent by sulpiride. In contrast, B(a)P had no effect on serotonin levels and activity in the two brain areas. In conclusion, PAHs, known environmental pollutants, even at relatively low consentrations may cause alterations in catecholamines of hypothalamus and hippocampus, at least in part, via D2 receptors. This may be of paramount significance for several vital functions of the exposed organism as these brain sites are related, among others, to cognitive functions and the regulation of homeostasis.
References 1.         Committee of Biologic Effects of Atmospheric Pollutants, Particulate Polycyclic Organic Matter, Div. Med. Sci. Natl. Res. Council National Academy of Science, Washington DC, 1972.

2.         Miller K.P., Ramos K.S.: Impact of cellular metabolism on the biological effects of benzo[a]pyrene and the related hydrocarbons. Drug Metab. Rev. 33(1): 1-35 (2001)

3.         Stephanou P., Konstandi M., Pappas P., Marselos M.: Alterations in central monoaminergic neurotransmission induced by polycyclic aromatic hydrocarbons in rats. Eur. J. Drug Metabol. Pharmacokinet. 23: 475-481 (1998)

4.         Rouet P., Alexandrov K., Markovits P., Frayssinet C.,

Dansette P.M.: Metabolism of benzo[a]pyrene by brain microsomes of fetal and adult rats and mice. Induction by 5,6 benzoflavone, comparison with liver and lung microsomal activities. Carcinogenesis 2. 919-926 (1981)

5.         Iscan M., Reuhl K., Weiss B., Maines M.D.: Regional and subcellular distribution of cytochrome P-450-dependent drug metabolism in monkey brain: the olfactory bulb and the mitochondrial fraction have high levels of activity. Bio- chem. Biophys. Res. Commun.169: 858-863 (1990)

6.         Jayasekara S., Sharma R.P., Drown D.B.: Effects of benzo[a]pyrene on steady-state levels of biogenic amines and metabolising enzymes in mouse brain regions. Ecotoxicol. Environ. Saf. 24(1):1-12(1992)

7.         Kriek E., Den Engelse L., Scherer E., Westra J.G.: Formation of DNA modifications by chemical carcinogens. Identification, localization and quantification. Biochim. Biophys. Acta Review 738(4): 181-201 (1984)

8.         Konstandi M., Pappas P., Johnson E., Lecklin A., Marselos M.: Suppression of the Acquisition of Conditioned Avoidance Behavior in the Rat by 3-Methylcholanthrene. Pharmacol. Biochem. Behavior56: 637-641,(1997)

9.         Lambert T.J., Velakoulis D., Pantelis C.: Medical comorbidity in schizophrenia. Med J Aust 178(9 Suppl): S67-70 (2003)

10.       Cooper J.R., Bloom F.E., Roth R.H.: In: The Biochemical Basis of Neuropharmacology (Seventh Edition), Norepinephrine and Epinephrine, Chapter 8, Adrenergic Receptors, Oxford University Press, New York, 1996

11.       Mefford I.N.: Application of high performance chroma-tography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. J. Neurosci. Methods 3: 207-224 (1081)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς –
What is Epitheorese Klinikes Farmakologias
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση –
Articles Published in Epitheorese Klinikes Farmakologias
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2004 – ANNUAL SUBSCRIPTION 2004
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

Bookmark the permalink.

Comments are closed.